SHANGHAI,March 6, 2018/PRNewswire/ — WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it had receivedAsia'sCMO of 2017at the 8th Annual BioPharma Industry Awards Ceremony.
The BioPharma Industry Awards Ceremony was held at 2018 Phar-East Asia Pharma & Biotech Festival on 1st March, 2018. The Biopharma Industry Awards aims to recognize the efforts, accomplishments and positive contributions of organizations and individuals inAsia'sbiopharmaceutical industry.
After seven years' rapid growth, WuXi Biologics has achieved several significant milestones. InDecember 2017, its biologics cGMP manufacturing facility in Wuxi city with 30,000 L bioreactor capacity entered into full operation. The new facility quintupledthe existing manufacturing capability of WuXi Biologics and further strengthenedits position as a global premier biologics manufacturer. The new facility in Wuxi deliveredadditional capacity, greater flexibility and higher efficiency to WuXi Biologics' customers.
"WuXi Biologics is honored to be recognized by the Biopharma Industry Awards," said Dr.Chris Chen, Chief Executive Officer of WuXi Biologics. "We greatly appreciate the continued trust and support from our customers and partners. The award truly reflects all of the efforts we have put forth to provide our customers with high-quality and best-in-class service to accelerate and transform biologics development from concept to commercialization. We strive to enable WuXi Biologics to become the most comprehensive capability and technology platformin the fast growing field of biologics to benefit patients worldwide."
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.